Log in

NASDAQ:RIGLRigel Pharmaceuticals SEC Filings & 10K Form

$1.82
-0.14 (-7.14 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.79
Now: $1.82
$2.13
50-Day Range
$1.78
MA: $1.89
$2.05
52-Week Range
$1.23
Now: $1.82
$3.10
Volume3.32 million shs
Average Volume2.08 million shs
Market Capitalization$306.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

SEC Filings

Rigel Pharmaceuticals (NASDAQ:RIGL) SEC Filings

DateFilerForm TypeView
05/15/2020
7:57 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:56 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:55 PM
Katkin Keith (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:53 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:53 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:52 PM
Goodwin Bradford S (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:51 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
7:50 PM
LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
3:15 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2020
4:19 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/01/2020
4:14 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
02/14/2020
3:21 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2020
3:44 PM
Rigel Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/07/2020
5:31 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:30 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:16 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:12 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
2:56 PM
Rigel Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/16/2020
2:13 PM
Rigel Pharmaceuticals (Filer)
Form CT ORDER
01/13/2020
3:05 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
4:04 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
7:23 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:20 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:18 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:15 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:11 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:06 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:05 PM
Dummer Wolfgang (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
3:05 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
4:45 PM
Dummer Wolfgang (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/14/2019
3:47 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/05/2019
3:10 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
6:41 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:05 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
7:34 PM
Rigel Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:09 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/24/2019
4:23 PM
Katkin Keith (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:21 PM
Goodwin Bradford S (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:19 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:18 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:17 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:15 PM
LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:08 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
7:21 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
6:40 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
3:21 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/09/2019
3:07 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/03/2019
5:36 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:29 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2019
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
6:28 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:26 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:25 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:24 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:23 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:22 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:19 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:17 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
8:48 AM
Rigel Pharmaceuticals (Filer)
Form CT ORDER
02/28/2019
3:02 PM
Rigel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
3:06 PM
GREAT POINT PARTNERS LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
9:00 AM
Rigel Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/06/2019
4:29 PM
BlackRock Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
4:25 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
5:55 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:53 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:51 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:41 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:36 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:32 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:23 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:20 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:17 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
6:35 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2018
7:10 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
5:46 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
8:00 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
5:26 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
6:48 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:02 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
6:49 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
6:12 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
5:16 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
4:18 PM
Rigel Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2018
3:34 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
3:11 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/05/2018
5:59 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2018
6:59 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2018
6:46 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2018
4:10 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2018
8:37 PM
Rigel Pharmaceuticals (Issuer)
RINGROSE PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:36 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:35 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:31 PM
LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:29 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:28 PM
Katkin Keith (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.